The Promise of Ketamine as a Rapid-Acting Antidepressant

April 22, 2023

Lutz, Florida USA (Newsworthy.ai) Saturday Apr 22, 2023 @ 7:00 AM Pacific —

Ketamine is a medication that has been used for decades as an anesthetic agent, but new research is unveiling its potential as a rapid-acting antidepressant.

Depression is a mental health condition that affects millions of individuals worldwide. The current medications used to treat it, such as SSRIs, can take weeks or months before patients start seeing any benefits. However, research into the potential of Ketamine as a rapid-acting antidepressant is pointing to very promising results.

According to recent studies, the administration of low doses of Ketamine intravenously has been shown to relieve depressive symptoms within hours of being given to patients. More encouragingly, remission of symptoms may last up to one week, giving doctors and researchers additional time to develop long-term treatment plans alongside traditional therapies.

While more research and clinical trials are needed, the results obtained until now show that Ketamine could be a highly beneficial treatment for the millions of individuals currently suffering from depression. These findings could represent a major turning point in how doctors and researchers approach the treatment of depression.

The rapid-acting nature of Ketamine could make a tremendous impact on the lives of people suffering from depression.

The promising results of Ketamine for the treatment of depression have opened the door for further research and clinical trials. If successful, Ketamine could be a revolutionary treatment for depression and offer new hope for the millions of people affected by this condition.

About Turning Point Wellness Center

Turning Point Wellness Center is dedicated to providing innovative and effective solutions to help patients improve their mental and physical well-being. At Turning Point, we specialize in providing Ketamine treatments as an alternative to traditional psychiatric medications. We believe that patients deserve to have access to safe and effective treatments without the negative side effects associated with prescription drugs. In addition to Ketamine, we also offer hydration and nutrient IV therapy.


This press release is distributed by the Newsworthy.ai™ Press Release Newswire – News at the speed of influence™. Reference URL for this press release is here.

Renowned Tibetan Medical Physician Brings 50 Years of Experience to Jampha’s Unique Botanical Products

Renowned Tibetan Medical Physician Brings 50 Years of Experience to Jampha’s Unique Botanical Products

May 31, 2023 Alex Halperin
Blaine, WA (Newsworthy.ai) Wednesday May 31, 2023 @ 11:11 AM Eastern — Jampha, a plant-based health and wellness company, offers a unique range of herbal infusions, Tibetan pills, and topicals to support specific health needs. What sets them apart is...
Jointly and Cova Collaborate to Transform Cannabis Retail with Jointly Matches, the First Goal-Based Data-Driven Sales Platform

Jointly and Cova Collaborate to Transform Cannabis Retail with Jointly Matches, the First Goal-Based Data-Driven Sales Platform

May 31, 2023 Alex Halperin
Los Angeles, CA (Newsworthy.ai) Wednesday May 31, 2023 @ 9:30 AM Eastern — Jointly, a cannabis discovery and software company, today announced a groundbreaking partnership with Cova, a leading provider of cannabis point of sale (POS) software. This collaboration offers...
Canopyright Launches The Cannabis Industry’s First Hashgraph-Secured Genetic Marketplace

Canopyright Launches The Cannabis Industry’s First Hashgraph-Secured Genetic Marketplace

April 25, 2023 Alex Halperin
San Francisco, CA (Newsworthy.ai) Tuesday Apr 25, 2023 @ 9:15 AM Pacific — Canopyright, a patent-pending, blockchain-powered marketplace that puts breeders' rights first, today announced the full launch of its cultivar marketplace purpose-built for cannabis breeders and commercial operators. Canopyright’s...